Expertise in
18
conditions

Dr. Walter W. Chatham

Rheumatology
Office
1707 W Charleston Blvd Ste 230, 
Las Vegas, NV 
Accepting New Patients
Expertise in
18
conditions
Office
1707 W Charleston Blvd Ste 230, 
Las Vegas, NV 

Overview

Walter Chatham is a Rheumatologist practicing medicine in Las Vegas, Nevada.

Dr. Chatham is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Sjogren Syndrome, and Granulomatosis with Polyangiitis.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 7 clinical trials. Dr. Chatham is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in AL

Hospital Affiliations

University Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
Silversummit Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Office
1707 W Charleston Blvd Ste 230, Las Vegas, NV 89102

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 104-Week Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Drug
Study Drugs: Rituximab, Standard therapy (Including Immunosuppressants), Standard therapy (Excluding Immunosuppressants), Steroid Taper
Study Phase: Phase 3
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of VIB1116 in Conventional Dendritic Cell (cDC) and Plasmacytoid Dendritic Cell (pDC)-Mediated Rheumatic Diseases
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of VIB1116 in Conventional Dendritic Cell (cDC) and Plasmacytoid Dendritic Cell (pDC)-Mediated Rheumatic Diseases
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
A Multi-center, Randomized, Double-blinded, Placebo-controlled, Multiple-ascending-dose Study of Brentuximab Vedotin in Adults With Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: June 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

9 Total Publications

Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome.
Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm Syndrome.
Journal: Viruses
Published: June 25, 2025
Similar Doctors
Expertise in
31
conditions
Dr. Farheen Rasool
Rheumatology
Expertise in
31
conditions
Dr. Farheen Rasool
Rheumatology
Referral required
Before you request

Southwest Medical Associates

4475 S Eastern Ave, 
Las Vegas, NV 
 (4.5 miles away)
702-877-5199
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Farheen Rasool is a Rheumatologist practicing medicine in Las Vegas, Nevada. Dr. Rasool is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Raynaud Phenomenon, Sjogren Syndrome, Scleroma, and Systemic Sclerosis (SSc). Dr. Rasool is board certified in American Board Of Internal Medicine. Dr. Rasool is currently accepting new patients.

Expertise in
17
conditions
Dr. George T. Kelly
Rheumatology
Expertise in
17
conditions
Dr. George T. Kelly
Rheumatology
Referral may be required

George T. Kelly, M.D.

7200 Cathedral Rock Dr Ste 110, 
Las Vegas, NV 
 (5.6 miles away)
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

George Kelly is a Rheumatologist practicing medicine in Las Vegas, Nevada. Dr. Kelly is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Osteoporosis, and Postmenopausal Osteoporosis. Dr. Kelly is currently accepting new patients.

Expertise in
5
conditions
Dr. Naya Mckinnon
Rheumatology
Expertise in
5
conditions
Dr. Naya Mckinnon
Rheumatology
Referral may be required
Before you request

Direct Access Rheumatology

2400 S Cimarron Rd, Suite 120, 
Las Vegas, NV 
 (4.6 miles away)
725-293-5101
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr Naya McKinnon is a board certified Rheumatologist. She specializes in providing integrative rheumatology care to people with autoimmune conditions. Dr. Mckinnon is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Sjogren Syndrome, Fibromyalgia, and Psoriasis. Dr. Mckinnon is board certified in Rheumatology.

Frequently Asked Questions about Dr. Walter W. Chatham

How do I make an appointment with Dr. Walter W. Chatham?

You can book an appointment with Dr. Walter W. Chatham by calling their office at 702-671-6469. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Walter W. Chatham a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Walter W. Chatham is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Walter W. Chatham specialize in?

While Dr. Walter W. Chatham is a Rheumatology, they have specific expertise in Systemic Lupus Erythematosus (SLE), Lupus Nephritis, and Sjogren Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Walter W. Chatham participate in research or clinical trials?

Yes. Dr. Walter W. Chatham has published 9 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Dr. Walter W. Chatham's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Walter W. Chatham accept my insurance?

Dr. Walter W. Chatham accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 702-671-6469 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chatham's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 48 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile